As of 1 January 2016, we have ended the practice of making payments to healthcare professionals (HCPs) to speak about our prescription medicines and vaccines to audiences who can prescribe or who can influence prescribing. We have also ended the practice of providing direct financial support for individual HCPs to attend medical conferences.

We acknowledge the importance of increased transparency and of putting the patient at the centre of every decision we take.